期刊文献+

欧盟化妆品不良反应关联性评价方法简介 被引量:5

Introduction to Causality Assessment Method of Cosmetic Adverse Reactions in European Union
下载PDF
导出
摘要 通过从评价方法的制定原则、制定标准和应用操作3方面详细介绍了欧盟化妆品不良反应关联性评价方法。欧盟化妆品不良反应关联性评价方法有着严格和缜密的制定原则,以及易于理解的评价逻辑,并采用了操作性强的决策树模式开展评价。该方法对于我国化妆品不良反应监测工作有着积极的借鉴意义。 This article introduced the formulation principles, standards and operation of the causality assessment method of cosmetic adverse reactions in EU. This method has strict and rigorous formulation principles and easily understood evaluation logic. The adopted decision tree mode is the most critical. This method is meaningful for cosmetic adverse reactions monitoring work in China.
出处 《中国药物警戒》 2014年第3期140-143,共4页 Chinese Journal of Pharmacovigilance
关键词 化妆品不良反应 关联性评价 方法 cosmetic adverse reactions causality assessment method
  • 相关文献

参考文献1

二级参考文献26

  • 1[1]Lazarou J,Pomeranz BH,Corey PN.Incidence of adverse drug reactions in hospitalized patients:a meta-analysis of prospective studies[J].JAMA.1998,279(15):1200-1205.
  • 2[2]Nelson KM,Talbert RL.Drug-related hospital admissions[J].Pharmacotherapy.1996,16(4):701-707.
  • 3[3]Michael TA.The oesophageal obturator airway[J].Br Med J (Clin Res Ed).1981,282(6272):1318.
  • 4[4]Bate A,Lindquist M,Edwards IR,Olsson S,Orre R,Lansner A,De Freitas RM.A Bayesian neural network method for adverse drug reaction signal generation[J].Eur J Clin Pharmacol.1998,54(4):315-321.
  • 5[5]Rawson NS,Pearce GL,Inman WH.Prescription-event monitoring:methodology and recent progress[J].J Clin Epidemiol.1990,43(5):509-522.
  • 6[6]Mann R.Prescription-event monitoring:its important role in ensuring new drug safety[M].Prescriber.1996.
  • 7[9]Fattinger K,Roos M,Vergeres P,Holenstein C,Kind B,Masche U,Stocker DN,Braunschweig S,Kullak-Ublick GA,Galeazzi RL,Follath F,Gasser T,Meier PJ.Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine[J].Br J Clin Pharmacol.2000,49(2):158-167.
  • 8[10]Amery WK.Post-marketing drug safety management:a pharmaceutical industry perspective.Int J of risk & safety in medicine[J].Special issue.1994,5(2/3):243-250.
  • 9[11]Psaty BM,Koepsell TD,LoGerfo JP,et al.β-blockers and primary prevention of coronary heart disease in patients with high blood pressure[J].JAMA 1989,261:2087-2094.
  • 10[12]Strom BL,Carson TL,Schinnar R,et al.Is cimetidine associated with neutropenia?[J].Am J Med.1995,99(3):282-290.

共引文献26

同被引文献38

  • 1霍本兴,王公昊,姚孝元,王秋水,刘悦,王铃芬.化妆品不良反应监测管理系统的研发[J].卫生研究,2007,36(4):525-527. 被引量:1
  • 2European Commission. Impact assessment report on simplification of the"Cosmetic Directive"-Directive 76/768/EEC[EB/OL]. (2008- 05-02 )[2015-4)4-08]. http://ec.europa.eu/transparency/regdoc/rep/2/ 2008/EN/2 -2008 - 117 -EN- 1-0. Pdf.
  • 3De Groot A C, Nater J P, Lender 1L et al. Adverse effects of cosmetics and toiletries: a retrospective study in the general population[J]. Int J Cosmet Sci, 1987, 9(6):255-259.
  • 4The European Parliament and of the Council. Council Directive 93/35/EEC of 14 June 1993 amending for the sixth time Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products[EB/OL].(1993-06-14)[2015- 04-08].http://publications.europa.eu/en/publication-detail/-/pub- lication/4bbSb985-2b83-4230-b 18c-f99fb3a7eSd7/language-.en/format-PDFAIB/source-541425.
  • 5The European Parliament and of the Council. Council Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products (Text with EEA relevance) [EB/OL].(2003-11-03)[2015- 04-08]. http://publications.europa.eu/en/publication-detaill-/ publication/60a70768-2dcf-4771-87b2-194ed4ec0012/1anguage- en/format-PDF/source-541233.
  • 6Berit Granum,Martinus Lowik. National Register of Adverse Ef- fects from Cosmetic Products 2008-2010 [EB/OL].(2011-03)[2015- 04-08]. http://www.fhi.no/dokumenter/df751 a6d55.pdf.
  • 7Sautebin L. A cosmetovigilance survey in Europe [J].Pharmacol Rev,2007,55(5):455-460.
  • 8SplrtielloL,Cammarota S, de portoS,et al.Notification of undesir- able effects of cosmetics and toiletries[J]. Pharmacol Res, 2009,59(2): 101-106.
  • 9de Wit-Bos L. Salverda-Nijhof J G.Cosmetovigilance in The Netherlands;Trend report 2011-2012 [EB/OL].(2013-03-01)[2015- 04-08]. http://www.rivm.nl/bibliotheek/rapporten/320113005.pdf.
  • 10Tammela M,Linderget M,IsakssonM.Patch testing with own cos-metics-a prospective study of testing and reporting of adverse effects to the Swedish medical products agency[J] .Contact dermatitis, 2012, 67(1):42-46.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部